119 related articles for article (PubMed ID: 31554952)
21. Artemether Exhibits Amoebicidal Activity against Acanthamoeba castellanii through Inhibition of the Serine Biosynthesis Pathway.
Deng Y; Ran W; Man S; Li X; Gao H; Tang W; Tachibana H; Cheng X
Antimicrob Agents Chemother; 2015 Aug; 59(8):4680-8. PubMed ID: 26014935
[TBL] [Abstract][Full Text] [Related]
22. Oleic acid-conjugated silver nanoparticles as efficient antiamoebic agent against Acanthamoeba castellanii.
Anwar A; Abdalla SAO; Aslam Z; Shah MR; Siddiqui R; Khan NA
Parasitol Res; 2019 Jul; 118(7):2295-2304. PubMed ID: 31093751
[TBL] [Abstract][Full Text] [Related]
23. In vitro evaluation of the amoebicidal activity of garlic (Allium sativum) extract on Acanthamoeba castellanii and its cytotoxic potential on corneal cells.
Polat ZA; Vural A; Ozan F; Tepe B; Ozcelik S; Cetin A
J Ocul Pharmacol Ther; 2008 Feb; 24(1):8-14. PubMed ID: 18370873
[TBL] [Abstract][Full Text] [Related]
24. Can artificial tears prevent Acanthamoeba keratitis? An in vitro approach.
Magnet A; Gomes TS; Pardinas C; Garcia de Blas N; Sadaba C; Carrillo E; Izquierdo F; Del Castillo JMB; Hurtado C; Del Aguila C; Fenoy S
Parasit Vectors; 2018 Jan; 11(1):50. PubMed ID: 29357901
[TBL] [Abstract][Full Text] [Related]
25. Autofluorescence Signatures of Seven Pathogens: Preliminary in Vitro Investigations of a Potential Diagnostic for Acanthamoeba Keratitis.
Molyneux PM; Kilvington S; Wakefield MJ; Prydal JI; Bannister NP
Cornea; 2015 Dec; 34(12):1588-92. PubMed ID: 26488626
[TBL] [Abstract][Full Text] [Related]
26. Polyhexamethylene biguanide and chloroquine induce programmed cell death in Acanthamoeba castellanii.
Moon EK; Choi HS; Kong HH; Quan FS
Exp Parasitol; 2018 Aug; 191():31-35. PubMed ID: 29885293
[TBL] [Abstract][Full Text] [Related]
27. Effect of non-steroidal anti-inflammatory drugs on biological properties of Acanthamoeba castellanii belonging to the T4 genotype.
Siddiqui R; Lakhundi S; Iqbal J; Khan NA
Exp Parasitol; 2016 Sep; 168():45-50. PubMed ID: 27381503
[TBL] [Abstract][Full Text] [Related]
28. Nanoemulsions Containing a Coumarin-Rich Extract from Pterocaulon balansae (Asteraceae) for the Treatment of Ocular Acanthamoeba Keratitis.
Panatieri LF; Brazil NT; Faber K; Medeiros-Neves B; von Poser GL; Rott MB; Zorzi GK; Teixeira HF
AAPS PharmSciTech; 2017 Apr; 18(3):721-728. PubMed ID: 27225384
[TBL] [Abstract][Full Text] [Related]
29. A DNA dot hybridization model for molecular diagnosis of parasitic keratitis.
Huang FC; Hsieh HY; Chang TC; Su SL; Tseng SL; Lai YH; Kuo MT
Mol Vis; 2017; 23():614-623. PubMed ID: 28867932
[TBL] [Abstract][Full Text] [Related]
30. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
Mrva M; Garajová M; Lukáč M; Ondriska F
J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
[TBL] [Abstract][Full Text] [Related]
31. Acanthamoeba in the eye, can the parasite hide even more? Latest developments on the disease.
Juárez MM; Tártara LI; Cid AG; Real JP; Bermúdez JM; Rajal VB; Palma SD
Cont Lens Anterior Eye; 2018 Jun; 41(3):245-251. PubMed ID: 29273391
[TBL] [Abstract][Full Text] [Related]
32. Encystment in Acanthamoeba castellanii: a review.
Lloyd D
Exp Parasitol; 2014 Nov; 145 Suppl():S20-7. PubMed ID: 24726698
[TBL] [Abstract][Full Text] [Related]
33. Programmed cell death in Acanthamoeba castellanii Neff induced by several molecules present in olive leaf extracts.
Sifaoui I; López-Arencibia A; Martín-Navarro CM; Reyes-Batlle M; Wagner C; Chiboub O; Mejri M; Valladares B; Abderrabba M; Piñero JE; Lorenzo-Morales J
PLoS One; 2017; 12(8):e0183795. PubMed ID: 28859105
[TBL] [Abstract][Full Text] [Related]
34. [Investigation of the in vitro effects of Melissa officinalis L., Mentha x piperita L. and Ocimum basilicum L. (Lamiaceae) essential oils on the cysts and trophozoites of Acanthamoeba castellani].
Ergüden C; Özkoç S; Öztürk B; Bayram Delibaş S
Mikrobiyol Bul; 2016 Oct; 50(4):569-579. PubMed ID: 28124962
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
36. Dacryoadenitis and extraocular muscle inflammation associated with contact lens-related Acanthamoeba keratitis: A case report and review of the literature.
Sengor T; Yuzbasioglu E; Aydın Kurna S; Irkec M; Altun A; Kökcen K; Yalcin NG
Orbit; 2017 Feb; 36(1):43-47. PubMed ID: 27874294
[TBL] [Abstract][Full Text] [Related]
37. Treatment of infectious keratitis with riboflavin and ultraviolet-A irradiation.
Chan E; Snibson GR; Sullivan L
J Cataract Refract Surg; 2014 Nov; 40(11):1919-25. PubMed ID: 25262564
[TBL] [Abstract][Full Text] [Related]
38. Tigecycline inhibits proliferation of Acanthamoeba castellanii.
Jha BK; Seo I; Kong HH; Suh SI; Suh MH; Baek WK
Parasitol Res; 2015 Mar; 114(3):1189-95. PubMed ID: 25563616
[TBL] [Abstract][Full Text] [Related]
39. Clinical and histologic evaluations of experimental Acanthamoeba keratitis.
Polat ZA; Ozcelik S; Vural A; Yildiz E; Cetin A
Parasitol Res; 2007 Nov; 101(6):1621-5. PubMed ID: 17701053
[TBL] [Abstract][Full Text] [Related]
40. In vitro amoebicidal activity of Salvia staminea and Salvia caespitosa on Acanthamoeba castellanii and their cytotoxic potentials on corneal cells.
Goze I; Alim A; Dag S; Tepe B; Polat ZA
J Ocul Pharmacol Ther; 2009 Aug; 25(4):293-8. PubMed ID: 19450152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
